https://orcid.org/0000-0002-2700-017X
References
- Sungurtekin U, Fraser IS, Shearman RP. Pregnancy in women with Kallmann’s syndrome. Fertil Steril. 1995;63(3):494–499. doi:10.1016/S0015-0282(16)57415-9
- Fraietta R, Zylberstejn DS, Esteves SC. Hypogonadotropic hypogonadism revisited. Clinics. 2013;68(S1):81–88. doi:10.6061/clinics/2013(Sup01)09
- Waal DV. Application of gonadotropin releasing hormone in hypogonadotropic hypogonadism--diagnostic and therapeutic aspects. Eur J Endocrinol. 2004;151(Suppl_3):U89–U94. doi:10.1530/eje.0.151u089
- Martin KA, Hall JE, Adams JM, et al. Comparison of exogenous gonadotropins and pulsatile gonadotropin-releasing hormone for induction of ovulation in hypogonadotropic amenorrhea. J Clin Endocrinol Metab. 1993;77(1):125–129. doi:10.1210/jcem.77.1.8325934
- Balen AH, Braat DD, West C, et al. Cumulative conception and live birth rates after the treatment of anovulatory infertility: safety and efficacy of ovulation induction in 200 patients. Hum Reprod. 1994;9(8):1563–1570. doi:10.1093/oxfordjournals.humrep.a138750
- Balasch J, Miro F, Burzaco I, et al. The role of luteinizing hormone in human follicle development and oocyte fertility: evidence from in-vitro fertilization in a woman with long-standing hypogonadotrophic hypogonadism and using recombinant human follicle stimulating hormone. Hum Reprod. 1995;10(7):1678–1683. doi:10.1093/oxfordjournals.humrep.a136154
- Steiner AZ, Stanczyk FZ, Patel S, et al. Antimullerian hormone and obesity: insights in oral contraceptive users. Contraception. 2010;81(3):245–248. doi:10.1016/j.contraception.2009.10.004
- Streuli I, Fraisse T, Pillet C, et al. Serum antimullerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids. Fertil Steril. 2008;90(2):395–400. doi:10.1016/j.fertnstert.2007.06.023
- Guo-ping WA, Rui-fang WU, Fang HE. Application of low-dose hCG combined with hMG in ovulation induction in hypogonadotropin-induced hypogonadism. Int J Reprod Health Fam Plan. 2015;34(3):196–198. IN CHINA.
- Jee C, Ku SY, Suh CS, et al. Serum anti-Mullerian hormone and inhibin B levels at ovulation triggering day can predict the number of immature oocytes retrieved in in vitro fertilization cycles. J Korean Med Sci. 2008;23(4):657–661.
- Liu ZX, Yan WU. Progress in ovulation induction for hypogonadotropin-induced hypogonadism in women. Clin J Endocrinol Metab. 2015;31(1):83–85. IN CHINA.
- Yasmin E, Davies M, Conway G, et al. British Fertility Society: “Ovulation induction in WHO Type 1 anovulation: guidelines for practice” Produced on behalf of the BFS Policy and Practice Committee. Hum Fertil. 2013;16(4):228–234. doi:10.3109/14647273.2013.829673
- Jiang S, Kuang Y. Research Progress of assisted pregnancy treatment in patients with hypogonadotropin hypogonadism. J Shanghai Jiaotong Univ. 2017;37(01):128–133. IN CHINA.